Prevalence and Impact of Co-morbidity Burden as Defined by the Charlson Co-morbidity Index on 30-Day and 1- and 5-Year Outcomes After Coronary Stent Implantation (from the Nobori-2 Study).

Mamas

doi:10.1016/j.amjcard.2015.04.047

Prevalence and Impact of Co-morbidity Burden as Defined by the Charlson Co-morbidity Index on 30-Day and 1- and 5-Year Outcomes After Coronary Stent Implantation (from the Nobori-2 Study).

Mamas

Authors

Mamas Mamas m.mamas@keele.ac.uk

Citation

Mamas. (2015). Prevalence and Impact of Co-morbidity Burden as Defined by the Charlson Co-morbidity Index on 30-Day and 1- and 5-Year Outcomes After Coronary Stent Implantation (from the Nobori-2 Study). American Journal of Cardiology, 364-371. https://doi.org/10.1016/j.amjcard.2015.04.047

Acceptance Date	Apr 30, 2015
Publication Date	May 8, 2015
Journal	American Journal of Cardiology
Print ISSN	0002-9149
Publisher	Elsevier
Pages	364-371
DOI	https://doi.org/10.1016/j.amjcard.2015.04.047
Publisher URL	https://doi.org/10.1016/j.amjcard.2015.04.047